COVID-19背景下马拉色菌毛囊炎。

IF 2.3 Q3 INFECTIOUS DISEASES

Current Fungal Infection Reports Pub Date : 2023-01-01 DOI:10.1007/s12281-023-00450-8

Alejandro Barrera-Godínez, Grecia Figueroa-Ramos

{"title":"COVID-19背景下马拉色菌毛囊炎。","authors":"Alejandro Barrera-Godínez, Grecia Figueroa-Ramos","doi":"10.1007/s12281-023-00450-8","DOIUrl":null,"url":null,"abstract":"Purpose of review: To review recent literature on Malassezia folliculitis and explore its association with COVID-19.Recent findings: Reports of Malassezia folliculitis in the setting of COVID-19 are scarce. Shared characteristics between affected individuals include male sex, obesity, intensive care, and administration of systemic antibiotics and systemic steroids. Dexamethasone can potentially stimulate sebum production and therefore lead to Malassezia proliferation. The clinical picture of Malassezia folliculitis accompanying COVID-19 is similar to classic descriptions but tends to spare the face and predominates in occlusion sites.Summary: Malassezia folliculitis is under-recognized. Fever, sweating, occlusion, immobility, antibiotics, and dexamethasone contribute to COVID-19 patients developing Malassezia folliculitis. Antifungal therapy, together with correcting predisposing factors, is the mainstay of management. Future research should explore the relationship between systemic steroids and other acneiform reactions.","PeriodicalId":10813,"journal":{"name":"Current Fungal Infection Reports","volume":"17 1","pages":"71-76"},"PeriodicalIF":2.3000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886535/pdf/","citationCount":"0","resultStr":"{\"title\":\"Malassezia Folliculitis in the Setting of COVID-19.\",\"authors\":\"Alejandro Barrera-Godínez, Grecia Figueroa-Ramos\",\"doi\":\"10.1007/s12281-023-00450-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose of review: To review recent literature on Malassezia folliculitis and explore its association with COVID-19.Recent findings: Reports of Malassezia folliculitis in the setting of COVID-19 are scarce. Shared characteristics between affected individuals include male sex, obesity, intensive care, and administration of systemic antibiotics and systemic steroids. Dexamethasone can potentially stimulate sebum production and therefore lead to Malassezia proliferation. The clinical picture of Malassezia folliculitis accompanying COVID-19 is similar to classic descriptions but tends to spare the face and predominates in occlusion sites.Summary: Malassezia folliculitis is under-recognized. Fever, sweating, occlusion, immobility, antibiotics, and dexamethasone contribute to COVID-19 patients developing Malassezia folliculitis. Antifungal therapy, together with correcting predisposing factors, is the mainstay of management. Future research should explore the relationship between systemic steroids and other acneiform reactions.\",\"PeriodicalId\":10813,\"journal\":{\"name\":\"Current Fungal Infection Reports\",\"volume\":\"17 1\",\"pages\":\"71-76\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886535/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Fungal Infection Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s12281-023-00450-8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Fungal Infection Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12281-023-00450-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

摘要

综述目的:回顾马拉色菌毛囊炎的最新文献，探讨其与COVID-19的关系。最近发现:关于COVID-19背景下马拉色菌毛囊炎的报道很少。受影响个体的共同特征包括男性、肥胖、重症监护以及全身性抗生素和类固醇的使用。地塞米松可以潜在地刺激皮脂的产生，从而导致马拉色菌的增殖。马拉色菌性毛囊炎伴随COVID-19的临床表现与经典描述相似，但往往不影响面部，且主要发生在闭塞部位。总结:马拉色菌性毛囊炎未被充分认识。发烧、出汗、闭塞、不活动、抗生素和地塞米松会导致COVID-19患者发生马拉色菌性毛囊炎。抗真菌治疗，连同纠正易感因素，是主要的管理。未来的研究应探讨全身性类固醇与其他痤疮样反应之间的关系。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Malassezia Folliculitis in the Setting of COVID-19.

查看原文本刊更多论文

Malassezia Folliculitis in the Setting of COVID-19.

Purpose of review: To review recent literature on Malassezia folliculitis and explore its association with COVID-19.

Recent findings: Reports of Malassezia folliculitis in the setting of COVID-19 are scarce. Shared characteristics between affected individuals include male sex, obesity, intensive care, and administration of systemic antibiotics and systemic steroids. Dexamethasone can potentially stimulate sebum production and therefore lead to Malassezia proliferation. The clinical picture of Malassezia folliculitis accompanying COVID-19 is similar to classic descriptions but tends to spare the face and predominates in occlusion sites.

Summary: Malassezia folliculitis is under-recognized. Fever, sweating, occlusion, immobility, antibiotics, and dexamethasone contribute to COVID-19 patients developing Malassezia folliculitis. Antifungal therapy, together with correcting predisposing factors, is the mainstay of management. Future research should explore the relationship between systemic steroids and other acneiform reactions.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Current Fungal Infection Reports INFECTIOUS DISEASES-

CiteScore

3.10

自引率

7.10%

发文量

期刊介绍： This journal intends to provide clear, insightful, balanced contributions that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of fungal infections. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as advances in diagnosis, current and emerging management approaches, and genomics and pathogenesis. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. Commentaries from well-known figures in the field are also provided, and an international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research.